CANCER CROSSLINKS 2025
Bridging innovations to improve clinical outcomes for cancer patients.
The 17th Cancer Crosslinks will be presented on
Thursday, January 23, 2025
Daytime Educational Program 10:00 - 16:15 (CET) // Afternoon Networking Session from 16:15
On-site at Oslo Cancer Cluster Innovation Park with a digital option.
Location: Ullernchausseen 64, Oslo, Norway.
Distinguished speakers from UK, US and The Nordics as they address emerging diagnostic and treatment options for solid and hematological cancers.
On-site at Oslo Cancer Cluster Innovation Park with a digital option.
Location: Ullernchausseen 64, Oslo, Norway.
Distinguished speakers from UK, US and The Nordics as they address emerging diagnostic and treatment options for solid and hematological cancers.
Program
SESSION 1 - Advances in tumour-agnostic therapies for precision oncology
Opening keynote address
Text
Dr. Vivek Subbiah, Chief, Early-Phase Drug Development Unity, Sarah Cannon Research Institute (SCRI).
Text
Dr. Vivek Subbiah, Chief, Early-Phase Drug Development Unity, Sarah Cannon Research Institute (SCRI).
Text
Prof. Ruth Plummer, Professor, Newcastle University.
Prof. Ruth Plummer, Professor, Newcastle University.
SESSION 2 - The potential of cell therapies in haematological malignancies and beyond
Text
Prof. Magnus Essand, Professor, Uppsala University, Department of Immunology, Genetics and Pathology, Uppsala, Sweden.
Prof. Magnus Essand, Professor, Uppsala University, Department of Immunology, Genetics and Pathology, Uppsala, Sweden.
Text
Prof. Inge Marie Svane, Professor, MD, National Center for Cancer ImmuneTherapy – CCIT-DK Cancer Research UK Cambridge Institute, University of Cambridge, UK.
Prof. Inge Marie Svane, Professor, MD, National Center for Cancer ImmuneTherapy – CCIT-DK Cancer Research UK Cambridge Institute, University of Cambridge, UK.
Text
Ingrid Stenstadvold Ross, General secretary, Norwegian Cancer Society, Oslo, Norway.
Ingrid Stenstadvold Ross, General secretary, Norwegian Cancer Society, Oslo, Norway.
Text
Joel Hedlund, Title
Joel Hedlund, Title
Moderators
Moderators:
Else Marit Inderberg, Unit leader, Translation Research Unit, Section for Cell Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.
Åsmund Flobak, Associate Professor at Norwegian University of Science and Technology (NTNU), MD at The Cancer Clinic, St. Olav's University Hospital
Senior researcher at SINTEF, Trondheim, Norway.
Sigrid Bratlie, Title
Hege Sagstuen Haugnes, Title
Event 2024 - Travel Voucher
A limited number of travel vouchers were available for clinicians and healthcare personnel based in Norway (domestic travel, first come, first served).
Event 2024 - Reference Materials
Else Marit Inderberg, Unit leader, Translation Research Unit, Section for Cell Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.
Åsmund Flobak, Associate Professor at Norwegian University of Science and Technology (NTNU), MD at The Cancer Clinic, St. Olav's University Hospital
Senior researcher at SINTEF, Trondheim, Norway.
Sigrid Bratlie, Title
Hege Sagstuen Haugnes, Title
Event 2024 - Travel Voucher
A limited number of travel vouchers were available for clinicians and healthcare personnel based in Norway (domestic travel, first come, first served).
Event 2024 - Reference Materials
|
Organizer
|
Sponsors 2024
|
|
|
|
To learn more about previous Cancer Crosslinks events, visit the GALLERY.